CIBC Private Wealth Group
CATX icon

CIBC Private Wealth Group’s Perspective Therapeutics CATX Stock Holding History

CIBC Private Wealth Group’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-530
Closed -$2K – 1071
2018
Q2 		$2K Hold
530
– – ﹤0.01% 1851
2018
Q1 		$2K Hold
530
– – ﹤0.01% 1789
2017
Q4 		$2K Buy
+530
New +$2.47K ﹤0.01% 1807

Other funds holding CATX

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CWM
Cahaba Wealth Management Atlanta, Georgia $1.66B AUM 17.04% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

CIBC Private Wealth Group's CATX Position: Q3 2018 in Review

CIBC Private Wealth Group sold out of Perspective Therapeutics (CATX) in Q3 2018, closing a stake of 530 shares — an estimated $2K sold.

CIBC Private Wealth Group first reported a position in CATX in Q4 2017 and held it in 3 quarters. The position peaked at $2K in Q2 2018. 29 funds tracked by Wall St. Rank hold CATX as of Q3 2018.

  • CIBC Private Wealth Group reported no remaining Perspective Therapeutics position as of Q3 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 530 Perspective Therapeutics shares in Q3 2018, an estimated $2K.
  • CIBC Private Wealth Group first reported a position in Perspective Therapeutics in Q4 2017 and held it in 3 quarters.
  • CIBC Private Wealth Group's Perspective Therapeutics position peaked at $2K in Q2 2018.
  • 29 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2018.

Based on CIBC Private Wealth Group's 13F filing for Q3 2018, filed 14 Nov 2018.